Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

CONCLUSION: The highest strength of supporting evidence is for the recommendation of biologic agents including tumor necrosis factor inhibitors, and interleukin 12/23, 17, and 23 inhibitors.PMID:36319021 | DOI:10.3899/jrheum.220313
Source: J Rheumatol - Category: Rheumatology Authors: Source Type: research